Product Comparison

Comparison Options

• Print
• Email
• Export Compare

McKesson #	795986	911398	1199151	1199156	1199197
Description	Prevnar 13® Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2.2 mcg - 4.4 mcg / 0.5 mL Injection 0.5 mL	Pneumovax® 23 Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection 0.5 mL	PREVNAR 20™ Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2.2 mcg - 4.4 mcg / 0.5 mL Injection 0.5 mL	PREVNAR 20™ Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2.2 mcg - 4.4 mcg / 0.5 mL Injection 0.5 mL	Vaxneuvance™ Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2 mcg - 4 mcg - 30 mcg / 0.5 mL Injection 0.5 mL
Manufacturer #	00005197102	00006483703	00005200010	00005200002	00006432903
Brand	Prevnar 13®	Pneumovax® 23	PREVNAR 20™	PREVNAR 20™	Vaxneuvance™
Manufacturer	Pfizer (RSV Vaccines)	Merck	Pfizer (RSV Vaccines)	Pfizer (RSV Vaccines)	Merck
Invoice	PREVNAR 13, SYR 0.5ML (10/CT) 9WYETH	PNEUMOVAX, SYR 0.5ML (10/CT)	PREVNAR 20, PFS 0.5ML UD (10/CT)	PREVNAR 20, PFS 0.5ML UD	VAXNEUVANCE, SYR 0.5ML (10/BX)
	Log In to Order	Log In to Order	Log In to Order	Log In to Order	Log In to Order
Comparison
Alternate Manufacturer Number	1614650		2348563	2348530
Country of Origin	Unknown	United States	Unknown	Unknown	Ireland
Generic Drug Code	28232	43859	49791	49791	50034
Generic Drug Name	Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free	Pneumococcal 23 Vaccine Polyvalent	Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free	Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free	Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free
NDC Number	00005197102	00006483703	00005200010	00005200002	00006432903
Product Dating	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 180 days
Strength	2.2 mcg - 4.4 mcg / 0.5 mL	25 mcg / 0.5 mL	2.2 mcg - 4.4 mcg / 0.5 mL	2.2 mcg - 4.4 mcg / 0.5 mL	2 mcg - 4 mcg - 30 mcg / 0.5 mL
Type	Intramuscular	Intramuscular or Subcutaneous	Intramuscular	Intramuscular	Intramuscular
User	Indicated for People 6 Weeks to 5 Years of Age and for People 50 Years of Age and Older	Indicated for People 50 Years of Age and Older	Indicated for People 6 Weeks of Age and Older	Indicated for People 6 Weeks of Age and Older	Indicated for People 6 Weeks of Age and Older
Application	Pneumonia Vaccine	Pneumonia Vaccine	Pneumonia Vaccine	Pneumonia Vaccine	Pneumonia Vaccine
Container Type	Prefilled Syringe	Prefilled Syringe	Prefilled Syringe	Prefilled Syringe	Prefilled Syringe
Dosage Form	Injection	Injection	Injection	Injection	Injection
Storage Requirements	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration
UNSPSC Code	51201615	51201615	51201615	51201615	51201615
Volume	0.5 mL	0.5 mL	0.5 mL	0.5 mL	0.5 mL
Features and Benefits	In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F In adults 50 and older, Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F The tip cap and rubber plunger of the prefilled syringe do not contain latex Store Refrigerated at 2° to 8°C (36° to 46°F)	PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons Store unopened and opened vials at 2° - 8°C (36° - 46°F)	10 Per Package		VAXNEUVANCE™ is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older Children: Administer VAXNEUVANCE as a 4-dose series at 2, 4, 6 and 12 through 15 months of age Adults: Administer VAXNEUVANCE as a single dose in adults 18 years of age and older 10 Per Package